Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses
Open Access
- 1 January 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (2), 1116-1125
- https://doi.org/10.1074/jbc.m804860200
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation InjuryThe American Journal of Pathology, 2008
- Thrombospondin-2 Modulates Extracellular Matrix Remodeling during Physiological AngiogenesisThe American Journal of Pathology, 2008
- Gene Silencing of CD47 and Antibody Ligation of Thrombospondin-1 Enhance Ischemic Tissue Survival in a Porcine ModelAnnals of Surgery, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Blockade of Thrombospondin-1-CD47 Interactions Prevents Necrosis of Full Thickness Skin GraftsAnnals of Surgery, 2008
- Blocking Thrombospondin-1/CD47 Signaling Alleviates Deleterious Effects of Aging on Tissue Responses to IschemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid UptakePublished by Elsevier BV ,2007
- Increasing Survival of Ischemic Tissue by Targeting CD47Circulation Research, 2007
- Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxationBlood, 2006
- Interactions of thrombospondins with α4β1 integrin and CD47 differentially modulate T cell behaviorThe Journal of cell biology, 2002